ICU seastarmedical.com: Multiplikator Forward P/S

Logo grafis SeaStar Medical Holding Corp (ICU)

SeaStar Medical develops systems to combat systemic inflammation, leveraging the expertise of bioengineers. However, business success depends on the outcome of clinical trials, where a lack of data creates financial threats. The forward P/S based on forecasts demonstrates the current valuation relative to expected revenue, and this metric stands at 2.10. The humanitarian status of the development for renal failure minimizes geopolitical risks.

seastarmedical.com - Rasio kapitalisasi marang dodolan sing dikarepake ICU (periode 15.11.2024 - 16.11.2026)

Rincian metrik lan analitis perusahaan seastarmedical.com (ICU)

- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:SeaStar Medical Holding Corp (ICU)
Sampel barang SeaStar Medical Holding

Use this tool for a comparative asset analysis, as it maps current market capitalization against projected annual sales volume. The trend of the forward P/S valuation reflects the justification of multiples through revenue expansion rates, which for SeaStar Medical (ICU) is confirmed by exclusive access to the dialysis market due to FDA protection that eliminates competition in the kidney treatment niche.

Pesaing wigati

Rasio rega marang prakiraan pendapatan Dexcom CGM DXCM|Penumbra Corp (PEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Novanta Inc - Multiplikator Forward P/S|HAE (Haemonetics Corporation) - Kapitalisasi marang prakiraan pendapatan|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED Inc.) - Multiplikator Forward P/S|Pulse Corp (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator Forward P/S picardmedical.com (PMI)|Multiplikator Forward P/S SRDX (surmodics.com)|Multiplikator Forward P/S Senseonics Holdings, Inc. SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (Sanuwave Health Inc) - Multiplikator forward rega marang pendapatan|Prakiraan rega marang pendapatan Outset Medical OM|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep LENSAR Inc. LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical Inc. (RCEL)|Profound Medical Corporation (PROF) - Prakiraan rega marang pendapatan|Baird Medical Investment Holdings - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP Medical EDAP|Apyx Medical Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical ICCM|Pulmonx (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio Corp)|Rasio rega marang prakiraan pendapatan cytosorbents.com|Multiplikator forward rega marang pendapatan Sensus Healthcare, Inc. (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan vicarioussurgical.com RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|ibs.inc - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|Rega mangsa ngarep marang pendapatan PFSA (Profusa Inc.)|Multiplikator forward rega marang pendapatan SSKN|Rasio rega marang prakiraan pendapatan GCTK|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Venus Concept - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S NUWE (Nuwellis Corp)|Rega forward marang dodolan AEMD|ASXC - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Avinger, Inc (AVGR)|BSGM: Multiplikator Forward P/S|Cutera (CUTR) - Multiplikator Forward P/S|KNW (Know Labs) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Inari Medical (NARI)|Rasio rega marang prakiraan pendapatan nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical)